Results 191 to 200 of about 31,541 (206)

Lopinavir/ritonavir

Reactions Weekly, 2017
openaire   +2 more sources

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV‐1‐infected patients

British Journal of Clinical Pharmacology, 2005
A D R Huitema
exaly  

Lopinavir/ritonavir

Reactions Weekly, 2011
openaire   +1 more source

Effects of cytochrome P450 3A (CYP3A) and the drug transporters P‐glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir

British Journal of Pharmacology, 2010
Jh Beijnen, A D R Huitema
exaly  

Simultaneous Population Pharmacokinetic Model for Lopinavir and Ritonavir in HIV-Infected Adults

Clinical Pharmacokinetics, 2012
JOSÉ Moltó, Cristina Miranda, JOSÉ R Santos   +2 more
exaly  

Model‐based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin

British Journal of Clinical Pharmacology, 2013
Paolo Denti, Eric H Decloedt, Mats O Karlsson   +2 more
exaly  

Lopinavir/ritonavir

Reactions Weekly, 2014
  +4 more sources

Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans

Pharmaceutical Research, 2004
Hing L Sham, Dale J Kempf, Kennan C Marsh   +2 more
exaly  

Lopinavir/ritonavir

Reactions Weekly, 2018
openaire   +2 more sources

Lopinavir/ritonavir population pharmacokinetics in neonates and infants

British Journal of Clinical Pharmacology, 2011
Albert Faye
exaly